T 1552/22 vom 23.09.2024
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2024:T155222.20240923
- Datum der Entscheidung
- 23. September 2024
- Aktenzeichen
- T 1552/22
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 17168875.7
- IPC-Klasse
- A61F 2/24
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- ANNULOPLASTY IMPLANT
- Name des Antragstellers
- HVR Cardio Oy
- Name des Einsprechenden
- Edwards Lifesciences Corporation
- Kammer
- 3.2.01
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 53(c)European Patent Convention Art 54European Patent Convention Art 83European Patent Convention R 106Rules of procedure of the Boards of Appeal Art 11Rules of procedure of the Boards of Appeal Art 12(3)Rules of procedure of the Boards of Appeal Art 12(5)Rules of procedure of the Boards of Appeal Art 13(2)
- Schlagwörter
- Main and auxiliary request - Sufficiency of disclosure - (yes)
Main and auxiliary request - Exceptions to patentability - (no)
Main request - Novelty - (no)
Remital (no)
amendment after communication under Article 15(1) admitted (no)
objection sufficiently substantiated (no) - Orientierungssatz
- -
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with claims 1 to 12 according to the auxiliary request 1 submitted with the reply to the statement of grounds of appeal and a description to be adapted thereto.
3. The objection under Rule 106 EPC is dismissed.